Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene.

Kim V, Crapo J, Zhao H, Jones PW, Silverman EK, Comellas A, Make BJ, Criner GJ; COPDGene Investigators.

Ann Am Thorac Soc. 2015 Mar;12(3):332-9. doi: 10.1513/AnnalsATS.201411-518OC.

PMID:
25575351
2.

Airway wall thickness is increased in COPD patients with bronchodilator responsiveness.

Kim V, Desai P, Newell JD, Make BJ, Washko GR, Silverman EK, Crapo JD, Bhatt SP, Criner GJ; COPDGene Investigators.

Respir Res. 2014 Aug 8;15:84. doi: 10.1186/s12931-014-0084-3.

3.

Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene.

Lee JH, Cho MH, McDonald ML, Hersh CP, Castaldi PJ, Crapo JD, Wan ES, Dy JG, Chang Y, Regan EA, Hardin M, DeMeo DL, Silverman EK; COPDGene Investigators.

Respir Med. 2014 Oct;108(10):1469-80. doi: 10.1016/j.rmed.2014.07.018. Epub 2014 Aug 11.

4.

DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease.

Lee JH, McDonald ML, Cho MH, Wan ES, Castaldi PJ, Hunninghake GM, Marchetti N, Lynch DA, Crapo JD, Lomas DA, Coxson HO, Bakke PS, Silverman EK, Hersh CP; COPDGene and ECLIPSE Investigators.

Respir Res. 2014 Aug 20;15:97. doi: 10.1186/s12931-014-0097-y.

5.

IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease.

Lee JH, Cho MH, Hersh CP, McDonald ML, Wells JM, Dransfield MT, Bowler RP, Lynch DA, Lomas DA, Crapo JD, Silverman EK; COPDGene and ECLIPSE Investigators.

Am J Respir Cell Mol Biol. 2015 Mar;52(3):365-76. doi: 10.1165/rcmb.2014-0210OC.

PMID:
25101718
6.

Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene.

Wan ES, Castaldi PJ, Cho MH, Hokanson JE, Regan EA, Make BJ, Beaty TH, Han MK, Curtis JL, Curran-Everett D, Lynch DA, DeMeo DL, Crapo JD, Silverman EK; COPDGene Investigators.

Respir Res. 2014 Aug 6;15:89. doi: 10.1186/s12931-014-0089-y.

7.

Research capacity. Enabling the genomic revolution in Africa.

H3Africa Consortium, Rotimi C, Abayomi A, Abimiku A, Adabayeri VM, Adebamowo C, Adebiyi E, Ademola AD, Adeyemo A, Adu D, Affolabi D, Agongo G, Ajayi S, Akarolo-Anthony S, Akinyemi R, Akpalu A, Alberts M, Alonso Betancourt O, Alzohairy AM, Ameni G, Amodu O, Anabwani G, Andersen K, Arogundade F, Arulogun O, Asogun D, Bakare R, Balde N, Baniecki ML, Beiswanger C, Benkahla A, Bethke L, Boehnke M, Boima V, Brandful J, Brooks AI, Brosius FC, Brown C, Bucheton B, Burke DT, Burnett BG, Carrington-Lawrence S, Carstens N, Chisi J, Christoffels A, Cooper R, Cordell H, Crowther N, Croxton T, de Vries J, Derr L, Donkor P, Doumbia S, Duncanson A, Ekem I, El Sayed A, Engel ME, Enyaru JC, Everett D, Fadlelmola FM, Fakunle E, Fischbeck KH, Fischer A, Folarin O, Gamieldien J, Garry RF, Gaseitsiwe S, Gbadegesin R, Ghansah A, Giovanni M, Goesbeck P, Gomez-Olive FX, Grant DS, Grewal R, Guyer M, Hanchard NA, Happi CT, Hazelhurst S, Hennig BJ, Hertz- C, Fowler, Hide W, Hilderbrandt F, Hugo-Hamman C, Ibrahim ME, James R, Jaufeerally-Fakim Y, Jenkins C, Jentsch U, Jiang PP, Joloba M, Jongeneel V, Joubert F, Kader M, Kahn K, Kaleebu P, Kapiga SH, Kassim SK, Kasvosve I, Kayondo J, Keavney B, Kekitiinwa A, Khan SH, Kimmel P, King MC, Kleta R, Koffi M, Kopp J, Kretzler M, Kumuthini J, Kyobe S, Kyobutungi C, Lackland DT, Lacourciere KA, Landouré G, Lawlor R, Lehner T, Lesosky M, Levitt N, Littler K, Lombard Z, Loring JF, Lyantagaye S, Macleod A, Madden EB, Mahomva CR, Makani J, Mamven M, Marape M, Mardon G, Marshall P, Martin DP, Masiga D, Mason R, Mate-Kole M, Matovu E, Mayige M, Mayosi BM, Mbanya JC, McCurdy SA, McCarthy MI, McIlleron H, Mc'Ligeyo SO, Merle C, Mocumbi AO, Mondo C, Moran JV, Motala A, Moxey-Mims M, Mpoloka WS, Msefula CL, Mthiyane T, Mulder N, Mulugeta Gh, Mumba D, Musuku J, Nagdee M, Nash O, Ndiaye D, Nguyen AQ, Nicol M, Nkomazana O, Norris S, Nsangi B, Nyarko A, Nyirenda M, Obe E, Obiakor R, Oduro A, Ofori-Acquah SF, Ogah O, Ogendo S, Ohene-Frempong K, Ojo A, Olanrewaju T, Oli J, Osafo C, Ouwe Missi Oukem-Boyer O, Ovbiagele B, Owen A, Owolabi MO, Owolabi L, Owusu-Dabo E, Pare G, Parekh R, Patterton HG, Penno MB, Peterson J, Pieper R, Plange-Rhule J, Pollak M, Puzak J, Ramesar RS, Ramsay M, Rasooly R, Reddy S, Sabeti PC, Sagoe K, Salako T, Samassékou O, Sandhu MS, Sankoh O, Sarfo FS, Sarr M, Shaboodien G, Sidibe I, Simo G, Simuunza M, Smeeth L, Sobngwi E, Soodyall H, Sorgho H, Sow Bah O, Srinivasan S, Stein DJ, Susser ES, Swanepoel C, Tangwa G, Tareila A, Tastan Bishop O, Tayo B, Tiffin N, Tinto H, Tobin E, Tollman SM, Traoré M, Treadwell MJ, Troyer J, Tsimako-Johnstone M, Tukei V, Ulasi I, Ulenga N, van Rooyen B, Wachinou AP, Waddy SP, Wade A, Wayengera M, Whitworth J, Wideroff L, Winkler CA, Winnicki S, Wonkam A, Yewondwos M, sen T, Yozwiak N, Zar H.

Science. 2014 Jun 20;344(6190):1346-8. doi: 10.1126/science.1251546. No abstract available.

8.

Comparison of HIV oral fluid and plasma antibody results during early infection in a longitudinal Nigerian cohort.

Luo W, Masciotra S, Delaney KP, Charurat M, Croxton T, Constantine N, Blattner W, Wesolowski L, Owen SM.

J Clin Virol. 2013 Dec;58 Suppl 1:e113-8. doi: 10.1016/j.jcv.2013.08.017.

PMID:
24342470
9.

Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial.

Woodruff PG, Chatila W, Connett JE, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Marchetti N, Rogers TJ, Scanlon PD, Sin DD, Voelker H, Wendt C, Albert RK; COPD Clinical Research Network.

Eur Respir J. 2014 Jan;43(1):295-8. doi: 10.1183/09031936.00140613. Epub 2013 Oct 17. No abstract available.

10.

Malfolded protein structure and proteostasis in lung diseases.

Balch WE, Sznajder JI, Budinger S, Finley D, Laposky AD, Cuervo AM, Benjamin IJ, Barreiro E, Morimoto RI, Postow L, Weissman AM, Gail D, Banks-Schlegel S, Croxton T, Gan W.

Am J Respir Crit Care Med. 2014 Jan 1;189(1):96-103. doi: 10.1164/rccm.201306-1164WS.

11.

The COPD Biomarker Qualification Consortium (CBQC).

Casaburi R, Celli B, Crapo J, Criner G, Croxton T, Gaw A, Jones P, Kline-Leidy N, Lomas DA, Merrill D, Polkey M, Rennard S, Sciurba F, Tal-Singer R, Stockley R, Turino G, Vestbo J, Walsh J.

COPD. 2013 Jun;10(3):367-77. doi: 10.3109/15412555.2012.752807.

PMID:
23713597
12.

Characterization of acute HIV-1 infection in high-risk Nigerian populations.

Charurat M, Nasidi A, Delaney K, Saidu A, Croxton T, Mondal P, Aliyu GG, Constantine N, Abimiku A, Carr JK, Vertefeuille J, Blattner W.

J Infect Dis. 2012 Apr 15;205(8):1239-47. doi: 10.1093/infdis/jis103. Epub 2012 Feb 21.

13.

Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy.

Casaburi R, Porszasz J, Hecht A, Tiep B, Albert RK, Anthonisen NR, Bailey WC, Connett JE, Cooper JA Jr, Criner GJ, Curtis J, Dransfield M, Lazarus SC, Make B, Martinez FJ, McEvoy C, Niewoehner DE, Reilly JJ, Scanlon P, Scharf SM, Sciurba FC, Woodruff P; COPD Clinical Research Network.

COPD. 2012 Feb;9(1):3-11. doi: 10.3109/15412555.2011.630048.

PMID:
22292592
14.

Azithromycin for prevention of exacerbations of COPD.

Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JA Jr, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Make B, Marchetti N, Martinez FJ, Madinger NE, McEvoy C, Niewoehner DE, Porsasz J, Price CS, Reilly J, Scanlon PD, Sciurba FC, Scharf SM, Washko GR, Woodruff PG, Anthonisen NR; COPD Clinical Research Network.

N Engl J Med. 2011 Aug 25;365(8):689-98. doi: 10.1056/NEJMoa1104623. Erratum in: N Engl J Med. 2012 Apr 5;366(14):1356.

15.

Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report.

Silverman EK, Vestbo J, Agusti A, Anderson W, Bakke PS, Barnes KC, Barr RG, Bleecker ER, Boezen HM, Burkart KM, Celli BR, Cho MH, Cookson WO, Croxton T, Daley D, DeMeo DL, Gan W, Garcia-Aymerich J, Hall IP, Hansel NN, Hersh CP, Kalsheker N, Kiley JP, Kim WJ, Lambrechts D, Lee SD, Litonjua AA, Lomas DA, London SJ, Nishimura M, Nørdestgaard BG, O'Donnell CJ, Postma DS, Puhan MA, Tesfaigzi Y, Tobin MD, Vogelmeier C, Wilk JB, Wouters E, Young RP, Ziegler-Heitbrock L, MacNee W, Crapo JD.

COPD. 2011 Apr;8(2):121-35. doi: 10.3109/15412555.2011.558864. No abstract available.

16.

Experiences in establishing a PEPFAR-supported laboratory quality system in Nigeria.

Abimiku AG, Croxton T, Akintunde E, Okelade B, Jugu J, Peters S, Dakum P, Blattner W, Constantine N.

Am J Clin Pathol. 2010 Oct;134(4):541-9. doi: 10.1309/AJCP5RP4QWEQLUZR.

17.

Methodology for using long-term accelerometry monitoring to describe daily activity patterns in COPD.

Hecht A, Ma S, Porszasz J, Casaburi R; COPD Clinical Research Network.

COPD. 2009 Apr;6(2):121-9. doi: 10.1080/15412550902755044.

18.

Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research.

Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM.

J Natl Cancer Inst. 2009 Apr 15;101(8):554-9. doi: 10.1093/jnci/djp023. Epub 2009 Apr 7.

19.

Chronic obstructive pulmonary disease: a view from the NHLBI.

Punturieri A, Croxton TL, Weinmann GG, Kiley JP.

Am J Respir Crit Care Med. 2008 Sep 1;178(5):441-3. doi: 10.1164/rccm.200807-1128OE. No abstract available.

20.

The changing face of COPD.

Punturieri A, Croxton TL, Weinmann G, Kiley JP.

Am Fam Physician. 2007 Feb 1;75(3):315-6. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk